Please login to the form below
statins
This page shows the latest statins news and features for those working in and with pharma, biotech and healthcare.
Sanofi, Regeneron offer price cut for cholesterol drug Praluent
Praluent (alirocumab) to high-dose statins reduced cardiovascular events and all-cause mortality compared to statins alone.
Latest news
-
Amgen gets prevention claim for cholesterol drug Repatha
and the risk of coronary revascularisation procedures by 22% over a two year-period when added to statin therapy.
-
The changing face of medical communications over the past 15 years
We used to work on products such as calcium-channel blockers, statins and ACE inhibitors.
-
CETP inhibitor class finally dies as Merck abandons anacetrapib
with placebo in patients at risk for cardiac events already on statin therapy after four years. ... in reducing cardiovascular events when added to statins.
-
US court lifts ban on sales of Sanofi's Praluent
Both products are used to treat patients who cannot meet cholesterol-lowering targets with existing therapy, such as statin drugs, or who have inherited disorders that cause elevated cholesterol. ... statins market has become generic and commoditised.
-
Merck & Co's anacetrapib data fails to generate much excitement
contend in the statin add-on market with PCSK9 inhibitors such as Amgen's Repatha, which showed a larger (15%) risk reduction in the FOURIER trial but are still struggling to ... to show a benefit in reducing cardiovascular events when added to statins.
More from news
Approximately 11 fully matching, plus 215 partially matching documents found.
Latest Intelligence
-
Holding on to hope for Alzheimer’s advances
In terms of BACE, Prof Roberts said: “Although the drug companies would love to have a drug that you could take like statins against hypercholesterolaemia, to give long-term protection against
-
Does safety sell medicines?
Statins - the most widely prescribed medicines on the planet - might not have been the success story they are without high quality pharmacovigilance detecting the risk of rhabdomyolysis and linking it to
-
Delivering accessible healthcare
Examples of how OTC can help tackle these pressures include the greater availability of statins in some countries and treatments for sexually transmitted diseases that do not require a prescription.
-
Shionogi: an expanding commercial focus
Perhaps best known for being the company that discovered the blockbuster statin Crestor (rosuvostatin), Shionogi has largely restricted its global focus to R&D.
-
Country report: The healthcare market in Germany
In 1996 new on-patent medicines became exempt unless they were part of classes such as statins to control the impact on spending on 'me-too' drugs.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
How do you define a biotech company?
benefit (eg: statins, PD-1s or TNFs).
-
The changing face of medical communications over the past 15 years
We used to work on products such as calcium-channel blockers, statins and ACE inhibitors.
-
The Missing Ingredient in Online Healthcare: Trust
topics, they may see a recommendation to check out an interactive quiz featuring key points of a statin’ s label.
-
Synergy Vision wins PharmaTimes Media International Communication Agency Team Award 2014
launched statin.
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Medical Writer, e-learning/ training, London
-
Excellent Salary
-
Scientific Director
-
Great salary and bebefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Account Manager – Med Comms – London
-
Salary TBC
-
Senior Medical Writer
-
Great salary and bebefits
-
Senior Medical Writer
-
Great salary and benefits
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Editor – Medical Education Agency – Bucks
-
Salary TBC
Subscribe to our email news alerts
No results were found
- P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
- Publicis LifeBrands Team win UK young Cannes Lions competition
- Sobi poaches Pfizer’s Fredrick Wetterlundh
- Rigel and Ultragenyx claim approvals for rare drugs
- VCCP Health strengthens client service team
- Is agile working benefiting the employee or the organisation?
PMHub
Digitas Health
Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....
Latest intelligence
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
- Unique forum will unite NHS and industry to drive innovation
- HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...
Quick links
Infographics
